Australia develops world-first foot and mouth vaccine to protect livestock
CANBERRA (ALETIHAD)A team of scientists in New South Wales has developed the world's first mRNA vaccine designed to protect livestock from foot-and-mouth disease (FMD), a highly contagious viral illness that poses a major threat to cattle.The FMD vaccine is an mRNA vaccine that is unique because it is fully synthetic, making it safer and much faster to produce.
The development of this new vaccine is part of the Minns Government's $1 billion biosecurity plan, aimed at safeguarding New South Wales' $8 billion livestock sector and reinforcing national food security.
The vaccine has taken less than 18 months to develop and has cost about $2.5 million.FMD is a highly infectious viral disease that affects cattle, sheep, goats, and pigs. It remains widespread globally and is endemic in many countries, particularly in Africa, Asia, and the Middle East.
In overseas trials of the new vaccine, innoculated cattle exposed to the virus did not contract the disease, and importantly, did not shed the virus to infect others.
Source: Aletihad - Abu Dhabi
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Etihad
2 hours ago
- Al Etihad
Harvard research on reversing Alzheimer's reveals lithium as potential key
6 Aug 2025 22:51 ABU DHABI (ALETIHAD)A decade of investigation by scientists at Harvard Medical School have revealed that the loss of the metal lithium plays a powerful role in Alzheimer's disease, a finding that could lead to earlier detection and new treatments for the disease that affects memory and cognitive led by Bruce A. Yankner, professor of genetics and neurology at Harvard Medical School, reported that they were able to reverse the disease in mice and restore brain function with small amounts of the compound lithium orotate, enough to mimic the metal's natural level in the brain. Their study appeared Wednesday in the journal findings are based on a series of experiments in mice and on analyses of human brain tissue and blood samples from individuals in various stages of cognitive scientists found that lithium loss in the human brain is one of the earliest changes leading to Alzheimer's, while in mice, similar lithium depletion accelerated brain pathology and memory team further found that reduced lithium levels stemmed from binding to amyloid plaques and impaired uptake in the brain. In a final set of experiments, the team found that a novel lithium compound that avoids capture by amyloid plaques restored memory in mice. The results unify decades-long observations in patients, providing a new theory of the disease and a new strategy for early diagnosis, prevention, and an estimated 400 million people worldwide, Alzheimer's disease involves an array of brain abnormalities — such as clumps of the protein amyloid beta, neurofibrillary tangles of the protein tau, and loss of a protective protein called REST — but these never explained the full story of the instance, some people with such abnormalities show no signs of cognitive decline. And recently developed treatments that target amyloid beta typically don't reverse memory loss and only modestly reduce the rate of decline. It is also clear that genetic and environmental factors affect risk of Alzheimer's, but scientists haven't figured out why some people with the same risk factors develop the disease while others do not. Lithium, the study authors said, may be a critical missing link.'The idea that lithium deficiency could be a cause of Alzheimer's disease is new and suggests a different therapeutic approach,' said senior author Bruce Yankner, professor of genetics and neurology in the Blavatnik Institute at HMS, who in the 1990s was the first to demonstrate that amyloid beta is study raises hopes that researchers could one day use lithium to treat the disease in its entirety rather than focusing on a single facet such as amyloid beta or tau, he of the main discoveries in the study is that as amyloid beta begins to form deposits in the early stages of dementia in both humans and mouse models, it binds to lithium, reducing lithium's function in the brain. The lower lithium levels affect all major brain cell types and, in mice, give rise to changes recapitulating Alzheimer's disease, including memory authors identified a class of lithium compounds that can evade capture by amyloid beta. Treating mice with the most potent amyloid-evading compound, called lithium orotate, reversed Alzheimer's disease pathology, prevented brain cell damage, and restored the findings need to be confirmed in humans through clinical trials, they suggest that measuring lithium levels could help screen for early Alzheimer's. Moreover, the findings point to the importance of testing amyloid-evading lithium compounds for treatment or lithium compounds are already used to treat bipolar disorder and major depressive disorder, but they are given at much higher concentrations that can be toxic, especially to older team found that lithium orotate is effective at one-thousandth that dose — enough to mimic the natural level of lithium in the brain. Mice treated for nearly their entire adult lives showed no evidence of lithium has not yet been shown to be safe or effective in protecting against neurodegeneration in humans, Yankner emphasises that people should not take lithium compounds on their own. But he expressed cautious optimism that lithium orotate or a similar compound will move forward into clinical trials in the near future and could ultimately change the story of Alzheimer's treatment. 'My hope is that lithium will do something more fundamental than anti-amyloid or anti-tau therapies, not just lessening but reversing cognitive decline and improving patients' lives,' he said. Source: Aletihad - Abu Dhabi
Al Etihad
13 hours ago
- Al Etihad
Cleveland Clinic Abu Dhabi introduces aquablation therapy for Benign Prostatic Hyperplasia
6 Aug 2025 12:26 ABU DHABI (ALETIHAD)In a groundbreaking advancement for prostate treatment, Cleveland Clinic Abu Dhabi has introduced aquablation therapy, a cutting-edge, minimally invasive procedure that brings new hope for men suffering from Benign Prostatic Hyperplasia (BPH). This innovative therapy is the first in the UAE to use a robotic-assisted waterjet solution for BPH, providing a new benchmark in precision and safety through real-time ultrasound guidance and robotic control, without the potential risks associated with heat-based to global studies, nearly 50% of men over the age of 60 are affected by BPH, with the prevalence rising to around 80% by age 85. The condition can lead to frequent urination, weak urinary flow, and, in advanced cases, urinary retention or incontinence, significantly impacting a patient's quality of life. Traditional treatments like medication and Transurethral Resection of the Prostate (TURP) surgery, which removes excess prostate tissue, may involve longer recovery periods and potential side effects in some cases. Aquablation offers a minimally invasive, heat-free alternative with faster recovery and a lower risk of side on the adoption, Dr. Georges-Pascal Haber, Chief Executive Officer at Cleveland Clinic Abu Dhabi, and a leading urologist specialising in robotic surgery, said: 'At Cleveland Clinic Abu Dhabi, we are committed to continuously advancing our medical capabilities and ensuring that the latest technologies, like the aquablation therapy, are available to our patients." He added, "It represents another milestone in our pursuit of providing the highest standards of care to our patients. We are deeply grateful for the ongoing support from the Department of Health- Abu Dhabi, which enables us to deliver world-class healthcare solutions right here in Abu Dhabi.' Dr. Waleed Hassen, Department Chair of Urology in the Surgical Subspecialties Institute at Cleveland Clinic Abu Dhabi, added: 'Aquablation therapy represents a new era in the treatment of benign prostatic hyperplasia (BPH), addressing the limitations of traditional techniques with remarkable precision and safety. We chose to bring this technology to Cleveland Clinic Abu Dhabi because it aligns with our mission of providing the most advanced, patient-centred care. Unlike conventional methods, aquablation is ideal for patients with even the most challenging prostate conditions, offering a level of customisation and predictability that has not been possible before.'Aquablation therapy utilises the AquaBeam® Robotic System, which delivers a heat-free, high-pressure waterjet to precisely remove prostate tissue. Unlike traditional methods that use heat (such as laser or electrocautery-based techniques), the non-thermal waterjet technology ensures minimal damage to surrounding tissues, significantly lowering the risk of side effects such as incontinence or sexual treatment is guided by real-time ultrasound imaging and cystoscopy, which allow the surgeon to visualise critical structures, such as the bladder neck, verumontanum, and external sphincter, ensuring their preservation. This combination of robotic precision and advanced imaging helps optimise outcomes and minimise risks. Dr. Zaki Almallah, Staff Physician, Urology, Surgical Subspecialties Institute, Cleveland Clinic Abu Dhabi, explained: "Aquablation therapy is truly revolutionary in treating benign prostatic hyperplasia. It is a one-time procedure that provides long-lasting symptom relief, with patients enjoying the benefits for years after treatment. By harnessing the power of robotic technology, we can now offer patients a treatment that is both highly effective and minimally invasive. It's the only treatment that provides real-time imaging of the entire prostate, allowing us to precisely remove excess tissue while preserving reproductive function. This means patients experience fewer side effects, faster recovery and a significant improvement in quality of life."Dr. Omer Raheem, Staff Physician, Urology, Surgical Subspecialties Institute, Cleveland Clinic Abu Dhabi, added: 'The robotic precision in the aquablation is truly transformative, especially for patients with larger prostates where traditional methods often fall short. The average resection time with aquablation is just 5.8 minutes, compared to nearly half an hour for TURP, without compromising on safety or effectiveness. It's an advanced solution that minimises risk, accelerates recovery, and offers patients an unmatched standard of care.'Cleveland Clinic Abu Dhabi's introduction of aquablation therapy is a testament to offering advanced treatment, aligning with its mission to deliver world-class, innovative healthcare solutions. As part of its Urology Program, which already provides a wide range of surgical and non-surgical treatments for complex bladder, kidney, and prostate conditions, the addition of aquablation further enhances the hospital's comprehensive care offering. In addition to aquablation therapy, Cleveland Clinic Abu Dhabi recently introduced Focal One High-Intensity Focused Ultrasound (HIFU) for prostate cancer, a non-invasive procedure that uses ultrasound waves to target and destroy cancer cells with high precision. These advances highlight Cleveland Clinic Abu Dhabi's leadership in urological care, offering patients in the UAE access to cutting-edge treatments that significantly improve outcomes and quality of life. Source: Aletihad - Abu Dhabi
Al Etihad
2 days ago
- Al Etihad
Future-ready UAE shows the world how foresight builds long-term resilience
5 Aug 2025 00:03 SARA ALZAABI (ABU DHABI) For the UAE, foresight is not only a strategic imperative but a national compass guiding institutions and communities through rapid developments and boosting long-term resilience, a leading futurist has told Aletihad . Dr. Sulaiman Al Kaabi, CEO of the Future Foresight Foundation, said foresight was no longer some obscure academic practice but had been built into governance and policymaking.'Today, the element of foresight is clearly present in every government plan or initiative,' he said.'The leadership recognises that remaining at the forefront of innovative nations requires a long-term vision and constant preparedness for unexpected changes. Foresight is not a luxury; it is part of the national identity.'An expert in strategic foresight and futures studies, Dr. Al Kaabi is the first person from the UAE and the Gulf region to join the Association of Professional Futurists (APF). He is also a member of the World Future Society (WFS). He authored the Future Foresight Encyclopaedia in Arabic, the first of its kind in the Arab represents a way of thinking — a formative value and an element of national identity, he said.'It begins from the outside in; it examines global changes and builds scenarios around them. Traditional planning [on the other hand] starts from the inside out, building on current capabilities,' Dr. Al Kaabi said. 'Foresight is the compass, and planning is the roadmap,' he said, stressing its importance in a fast-changing world of 'technological, social, and economic revolutions.'Foresight 'places the UAE in a position of initiative, not reaction'. It is evident in how the country is preparing for challenges such as AI's impact on the workforce, climate change, cybersecurity, and resource sustainability, Dr. Al Kaabi said. Foresight allows the UAE to act fast in times of crisis, with plans ready before problems arise, he said. He pointed to the UAE's swift COVID-19 response as proof of how foresight works; just as it underpins long-term goals like We the UAE 2031 and UAE Centennial 2071.'Foresight provides the country with the tools necessary to review its path and update its goals based on global developments,' Dr. Al Kaabi said. Leveraging New TechAI and big data have revolutionised how strategies are future-proofed, he added. Advanced technology now bolsters entities' ability to create 'accurate scenarios, faster decisions, and plans that can be adjusted instantly.' Future Foresight Foundation has been helping institutions build future-ready plans and stay ahead of emerging trends.'It is the first private foundation in the UAE and the Arabian Gulf to place scientific foresight at the core of its work,' Dr. Al Kaabi said. 'It specialises in conducting futures studies and developing practical, implementable scenarios.' The foundation collaborates with the public and private sectors and philanthropic organisations across the world through consultations, training courses, and strategic programmes to help them prepare for potential disruptions and capitalise on new opportunities. 'We are committed to applying globally recognised scientific methodologies and utilising the latest analytical and artificial intelligence tools to create accurate visions of the future,' Dr. Al Kaabi said. The foundation, for an instance, uses an Arab-developed foresight model based on global best practices. It uses big data and expert insights to build detailed, sector-specific scenarios. Foresight, he added, now drives progress in education, healthcare, energy, security, and the economy. Empowering the Youth Central to building future-ready strategies is empowering the youth, and the UAE has been on the right track when it comes to highlighting the importance of looking ahead. 'Young people are the fuel and engine of any real change… We must empower them to become the makers of the future,' Dr. Al Kaabi the country, foresight is being embedded in education, he added. 'We need foresight to be a fundamental component of the educational process, not just an additional subject or a side activity. With the UAE's clear vision and a future-focused mindset, the country has become 'an international reference in future thinking.' Dr. Al Kaabi said.
